Denosumab as the Treatment of Recalcitrant Tuberculous Pleural Effusion-Associated Hypercalcemia

Table 3

Serum calcium level after administration of subcutaneous denosumab.

Day (postdenosumab)	1	2	3	4	5	6	7	8
Corrected calcium level (mmol/L)	3.44	3.43	3.28	2.46	2.97	2.40	2.52	2.43
Serum creatinine level (μmol/L)	353	360	370	273	332	234	345	431